Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
Magis Pharma Group from Antwerpen, company number BE0765834004, closed financial year 2025 with a result of € -399,056 after tax. For that financial year Magis Pharma Group recorded revenue of € 868,488 and equity of € 530,028. Compared with financial year 2024, the result moved from € -9.4 million to € -399,056. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.
€ 530,028
▼ 43% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -399,056
▲ 96 % less loss than in 2024
Profit after tax over the fiscal year.
€ 11,511
▼ 86% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -9.8 million.
Debts at end 2025
€ 9.4 million
▲ 12% vs 2024
Loans from banks and other lenders, long and short.
€ 834,440
▼ 1% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 296 days on average.
€ 1,461
▼ 47% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 1,046,789 | € 830,630 | € 865,088 | € 868,488 | |
| Profit after taxes | € 456,247 | € -137,986 | € -9,438,535 | € -399,056 | ▲ € 9 million |
| Equity | € 11,322,121 | € 11,184,135 | € 929,084 | € 530,028 | ▼ 43% |
| Total debts | € 5,296,737 | € 7,705,354 | € 10,248,889 | € 12,459,139 | ▲ 22% |
| Cash | € 18,922 | € 8,065 | € 84,762 | € 11,511 | ▼ 86% |
| Retained profit | € 224,963 | € 86,977 | € -9,351,559 | € -9,750,615 | ▼ € 399,056 |
| Bank debt | € 4,680,000 | € 6,470,000 | € 8,380,000 | € 9,421,734 | ▲ 12% |
| Balance sheet total | € 16,618,857 | € 18,889,488 | € 11,177,973 | € 12,989,167 | ▲ 16% |
Key figures of Magis Pharma Group, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Magis Pharma Group?
What happened at Magis Pharma Group in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 399,056. Source: NBB ↗
- Green Monkey BV became a director. NBB
- Jeroen Van Der Hamsvoort became a director. NBB
- Paulus De Vogel became a director. NBB
- New establishment in Antwerpen. KBO
- Start of the company according to the CBE. KBO
In short
From € 456,247 profit in 2022 to € 399,056 loss in 2025.
Best year ever: 2022, with € 456,247 profit.
A new publication or filing at Magis Pharma Group? We notify you, reason included.
Follow Magis Pharma GroupDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Magis Pharma Group are Green Monkey BV, Paulus De Vogel and Jeroen Van Der Hamsvoort. It owns 100% of Magis-Pharma, 100% of Metapharmaceutical ind. S.L. and 100% of Parchim itself.
Directors
According to the 2025 annual accounts
Director · represented by Christophe Bouvry
Also active at: PARCHIM, Magis-Pharma, isomasters
since 2026
since 2022
Establishments
Establishment units
Physical locations of this company
Neerlandweg 24
2610 Antwerpen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0765.834.004
- VAT number
- BE 0765.834.004
- Registered office
- Neerlandweg 24, 2610 Antwerpen
- Names & denominations
- Magis Pharma Group
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 March 2021
- Peppol
- Active · Active since 6 Feb 2026
- Activities · NACE
Activiteiten van holdings
Holdings
Administratieve en ondersteunende activiteiten ten behoeve van kantoren
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige zakelijke dienstverlening, neg
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Handel in eigen onroerend goed
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
+2